CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC ...Middle East

PR Newswire - News
Commencement of the first-in-human clinical trial of CS5001 marks another key milestone for CStone's Pipeline 2.0 Global development of CS5001 is conducted in the form of a multi-regional clinical trial, with sites initiated in the US and Australia, and an IND application accepted by the...

Read More Details
Finally We wish PressBee provided you with enough information of ( CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC )

Also on site :